3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Graft vs Host Disease
3
Bronchiolitis Obliterans Syndrome
3
Leukemia, Lymphocytic, Chronic, B-Cell
2
Waldenstrom Macroglobulinemia
1
Recurrence
1
Anemia
1
Interventions
zanubrutinib
1
venetoclax
1
pirtobrutinib
1
ibrutinib
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Waldenstrom Macroglobulinemia
×
ibrutinib
×
Clear all
NCT03053440
2024-10-26
ASPEN
BeiGene
Phase 3
Completed
201 enrolled
19 charts
1 FDA